Zadik Z, Frishberg Y, Drukker A, Blachar Y, Lotan D, Levi S, Reifen R
Pediatric Endocrine Unit, Kaplan Medical Center, Rehovot, Israel.
Metabolism. 1998 Mar;47(3):264-8. doi: 10.1016/s0026-0495(98)90254-2.
Although diet and nutrition are an integral part of the management of individuals with chronic renal failure (CRF), little has been written on the effect of nutrition on the growth response to growth hormone (GH) in CRF. We studied the GH axis and nutritional status of 31 prepubertal children aged 8.7 +/- 0.5 years with a height standard deviation score (SDS) of -3.2 +/- 0.2 (mean +/- SEM) with CRF. Sixteen CRF patients on hemodialysis and 15 on peritoneal dialysis were studied. Forty-four age-matched normal short children without GH deficiency served as controls. Spontaneous 12-hour GH and stimulated GH values were significantly higher and GH binding protein (GHBP) was significantly lower in the CRF patients than in the normal short children. Both before the initiation of GH therapy and after the first year of treatment, the growth velocity (SDS) was inversely correlated with dietary protein intake and positively correlated with caloric intake. GH was administered at a dosage of 28 and 21 IU/m2/wk to the CRF group and the normal short children, respectively, divided into seven daily doses. The growth response of the normal short children was significantly greater than that of the CRF patients. GH therapy induced a smaller increment in GHBP and IGF-I in the CRF patients versus the normal short children (8.8 +/- 2.2 and 10.2 +/- 2.7 v 24.8 +/- 1.3 and 27.6 +/- 2.5 nmol/L, respectively, P < .01). The 1-year growth velocity of the CRF children was most closely correlated with dietary protein and caloric intake. The nutritional status of CRF patients is concluded to be a major factor in growth both before and during GH therapy.
尽管饮食和营养是慢性肾衰竭(CRF)患者治疗中不可或缺的一部分,但关于营养对CRF患者生长激素(GH)生长反应的影响却鲜有报道。我们研究了31名8.7±0.5岁青春期前CRF患儿的GH轴和营养状况,其身高标准差评分(SDS)为-3.2±0.2(均值±标准误)。研究对象包括16名接受血液透析的CRF患者和15名接受腹膜透析的患者。选取44名年龄匹配、无GH缺乏的身材矮小正常儿童作为对照。CRF患者的自发性12小时GH和刺激后GH值显著高于正常身材矮小儿童,而GH结合蛋白(GHBP)则显著低于正常身材矮小儿童。在开始GH治疗前及治疗第一年之后,生长速度(SDS)与饮食蛋白质摄入量呈负相关,与热量摄入量呈正相关。分别以28和21 IU/m²/周的剂量给CRF组和正常身材矮小儿童注射GH,分为每日7剂。正常身材矮小儿童的生长反应显著大于CRF患者。与正常身材矮小儿童相比,GH治疗使CRF患者的GHBP和胰岛素样生长因子-I(IGF-I)升高幅度较小(分别为8.8±2.2和10.2±2.7,对比24.8±1.3和27.6±2.5 nmol/L,P<0.01)。CRF患儿的1年生长速度与饮食蛋白质和热量摄入量的相关性最为密切。得出结论,CRF患者的营养状况是GH治疗前及治疗期间生长的主要因素。